BIT
UTHR icon

BlackRock Institutional Trust’s United Therapeutics UTHR Stock Holding History

BlackRock Institutional Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$204M Buy
1,420,538
+25,228
+2% +$3.22M 0.03% 573
2016
Q3 		$165M Sell
1,395,310
-111,711
-7% -$13.4M 0.03% 631
2016
Q2 		$160M Sell
1,507,021
-36,155
-2% -$4.03M 0.03% 635
2016
Q1 		$172M Sell
1,543,176
-117,842
-7% -$14.9M 0.03% 616
2015
Q4 		$260M Buy
1,661,018
+130,499
+9% +$19M 0.04% 435
2015
Q3 		$201M Buy
1,530,519
+21,467
+1% +$3.44M 0.04% 521
2015
Q2 		$263M Buy
1,509,052
+20,510
+1% +$3.69M 0.04% 435
2015
Q1 		$257M Buy
1,488,542
+32,185
+2% +$4.91M 0.04% 465
2014
Q4 		$189M Sell
1,456,357
-3,346
-0.2% -$431K 0.03% 569
2014
Q3 		$188M Sell
1,459,703
-249,974
-15% -$25.8M 0.03% 540
2014
Q2 		$151M Sell
1,709,677
-91,618
-5% -$8.81M 0.03% 670
2014
Q1 		$169M Buy
1,801,295
+29,397
+2% +$3.01M 0.03% 600
2013
Q4 		$200M Buy
1,771,898
+138,069
+8% +$12.5M 0.04% 498
2013
Q3 		$129M Buy
1,633,829
+174,669
+12% +$12.8M 0.02% 652
2013
Q2 		$96M Buy
+1,459,160
New +$94M 0.02% 773

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock Institutional Trust's UTHR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its United Therapeutics (UTHR) stake by 1.8% in Q4 2016, buying an estimated $3.22M and bringing the position to 1,420,538 shares worth $204M. The position accounts for 0.03% of the portfolio, ranked #573.

BlackRock Institutional Trust first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $263M in Q2 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • BlackRock Institutional Trust held 1,420,538 shares of United Therapeutics worth $204M as of Q4 2016.
  • BlackRock Institutional Trust bought 25,228 United Therapeutics shares in Q4 2016, an estimated $3.22M.
  • United Therapeutics made up 0.03% of BlackRock Institutional Trust's portfolio in Q4 2016, its #573 holding.
  • BlackRock Institutional Trust first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's United Therapeutics position peaked at $263M in Q2 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.